Werewolf Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Werewolf Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22% to $19,943,000. The net income raised on -$37,368,000 and profit margin reached -187%. Total operating expenses were $60,446,000.

Profit Margin

Werewolf Therapeutics, Inc. (NASDAQ:HOWL): Profit margin
2019 0 -10.99M
2020 0 -14.93M
2021 0 -49.76M
2022 16.40M -51.56M -314.4%
2023 19.94M -37.36M -187.37%

HOWL Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
19.94M16.40M000
Cost of revenue
38.90M2.51M735K777K463K
Gross profit
-18.96M13.89M-735K-777K-463K
Operating exp.
Research and development
41.77M53.76M35.26M16.64M6.34M
Selling and marketing
00000
Total operating expenses
60.44M72.45M50.08M22.40M9.93M
Operating income
-40.50M-56.05M-50.08M-22.40M-9.93M
Other income (expenses), net
3.13M2.24M104K7.36M-312K
Income before tax
-37.36M-53.81M-49.98M-15.04M-10.24M
Income tax expense
0-2.24M-216K-101K742K
Net income
-37.36M-51.56M-49.76M-14.93M-10.99M
Earnings per share
Basic EPS
-1.05-1.79-1.82-0.52-0.38
Diluted EPS
-1.05-1.79-1.82-0.52-0.38
Data sourceData sourceData source